Quest Diagnostics Incorporated (DGX)

Net profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 854,000 763,000 794,000 793,000 946,000 1,235,000 1,484,000 1,881,000 1,995,000 2,184,000 2,247,000 1,801,000 1,431,000 1,105,000 752,000 793,000 858,000 732,000 730,000 723,000
Revenue (ttm) US$ in thousands 9,100,000 9,153,000 9,351,000 9,467,000 9,745,000 10,142,000 10,425,000 10,520,000 10,628,000 10,932,000 10,982,000 10,297,000 9,437,000 8,361,000 7,531,000 7,657,000 7,726,000 7,639,000 7,572,000 7,538,000
Net profit margin 9.38% 8.34% 8.49% 8.38% 9.71% 12.18% 14.24% 17.88% 18.77% 19.98% 20.46% 17.49% 15.16% 13.22% 9.99% 10.36% 11.11% 9.58% 9.64% 9.59%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $854,000K ÷ $9,100,000K
= 9.38%

Quest Diagnostics, Inc.'s net profit margin has shown a decreasing trend over the past quarters. In Q4 2023, the net profit margin was 9.19%, which was lower compared to the previous quarter at 8.16% in Q3 2023. This decline continued from the higher levels seen in prior periods, such as 13.98% in Q3 2022 and 17.55% in Q1 2022. The downward trend in net profit margin could indicate challenges in controlling costs or maintaining revenue growth, impacting the company's overall profitability. Further analysis of the underlying factors contributing to this trend would be necessary to fully understand the dynamics at play.


Peer comparison

Dec 31, 2023

Company name
Symbol
Net profit margin
Quest Diagnostics Incorporated
DGX
9.38%
Fulgent Genetics Inc
FLGT
-58.03%
Laboratory Corporation of America Holdings
LH
3.24%
RadNet Inc
RDNT
0.19%